Long-term study of HIV patients in rural India

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Vicente Ferrer HIV Cohort Study is a long-term observational study focusing on HIV-infected patients in a rural area of India. It aims to collect routine clinical data to describe the epidemiology of HIV and its related conditions, as well as to evaluate the effectiveness of health interventions in a real-world setting. The study gathers comprehensive information on patient demographics, treatment regimens, and health outcomes, contributing to a better understanding of HIV in resource-poor environments. Data has been collected since 2009 at Bathalapalli Hospital, which provides free medical care to individuals living with HIV.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Positive serology for HIV

Exclusion Criteria:

* Refuse to consent

Where it's running

• RDT Hospital
  Battalapalli, Andhra Pradesh, India Recruiting

Study contacts

• Principal investigator: Gerardo Alvarez-Uria — Rural Development Trust
• Study coordinator: Gerardo Alvarez-Uria
• Email: hivbtp@gmail.com

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Reexamining how asymptomatic tuberculosis spreads

  This project will test whether people with asymptomatic tuberculosis—particularly adults living with HIV—can pass TB to their household and close contacts.

  Recruiting Barcelona Institute for Global Health · Manhiça, Maputo Province · NCT07312266

• Coach Mpilo peer support for men with TB and HIV

  We will test whether Coach Mpilo, a peer-support program developed by men, helps men starting TB treatment — including those with HIV — complete TB therapy and achieve better HIV viral suppression.

  Recruiting Arizona State University · East London · NCT07117370

• Validation of Treatment Decision Algorithms for Childhood Tuberculosis

  This study is testing a new way to help doctors in Zambia and Mozambique make better decisions for screening and treating tuberculosis in children under 15 years old.

  Recruiting at 29 sites University of Zambia · Chingola, Copperbelt and 28 other locations · NCT06593080

• Dolutegravir plus lamivudine two-drug HIV treatment for people starting rifampin-based TB therapy

  This will test whether a two-drug HIV regimen (dolutegravir plus lamivudine), given either twice daily or as Dovato in the morning plus extra dolutegravir in the evening, works and is safe for ART‑naïve people with HIV who are receiving rifampin-based tuberculosis treatment compared with standard three‑drug therapy.

  Recruiting at 5 sites Phase 3 Johns Hopkins University · Manaus, Amazonas and 4 other locations · NCT06497465

• Doxycycline added to standard treatment for central nervous system tuberculosis

  This trial tests whether adding doxycycline to standard anti‑TB therapy and corticosteroids helps adults with central nervous system tuberculosis live longer or have less severe neurological disability.

  Recruiting at 5 sites Phase 2 National University Hospital, Singapore · Medan, Medan and 5 other locations · NCT06446245

• Peer-led TB and HIV education and adherence counseling in Uganda

  This trial will test whether peer-led TB education and counseling helps adults with tuberculosis (with or without HIV) stick to treatment and have better health outcomes.

  Recruiting Yale University · Kampala · NCT05917210

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.